Squarepoint Ops LLC Seelos Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.59 - $2.38 $47,207 - $70,662	-29,690 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.69 - $2.89 $50,176 - $85,804	29,690 New	29,690 $72,000
Q2 2021 Aug 16, 2021	SELL	$2.64 - $6.32 $81,998 - $196,299	-31,060 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$1.35 - $4.99 $176,504 - $652,412	-130,744 Reduced 80.8%	31,060 $155,000
Q4 2020 Feb 16, 2021	BUY	$0.74 - $2.01 $119,734 - $325,226	161,804 New	161,804 $256,000

Q2 2020 Aug 14, 2020	SELL	$0.42 - $1.51 $7,297 - $26,234	-17,374 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$0.47 - $1.56 $1,798 - $5,968	-3,826 Reduced 18.05%	17,374 $9,000
Q4 2019 Feb 14, 2020	SELL	$0.72 - $1.52 $1,533 - $3,237	-2,130 Reduced 9.13%	21,200 $28,000
Q3 2019 Nov 14, 2019	SELL	$0.92 - $2.15 $4,875 - $11,392	-5,299 Reduced 18.51%	23,330 $21,000
Q2 2019 Aug 14, 2019	BUY	$2.11 - $3.3 $60,407 - $94,475	28,629 New	28,629 $63,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $64M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.